About Vertisense
Vertisense was a Healthcare company based in New York (United States) founded in 2011 by Ben Biron and Max Koeppel. It develops innovative connected breathalyzer technologies for health and safety applications. It operates on a B2B model. Vertisense has raised $2.33 million across 6 funding rounds from investors including Techstars and RevTech Labs. The company is recorded as dissolved. Its focus areas include Technology, Health Technology, Wearables and Breathalyzer Devices. Its competitors include Scram Systems, Transbiotec and Quantac; 1 of its 3 listed competitors has raised funding.
Company details
Vertisense operates with a B2B model, focusing on leveraging cutting-edge technology, advancing health solutions through tech, developing wearables, and breathalyzer devices. Develops innovative connected breathalyzer technologies for health and safety applications. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
- Headquarters New York, United States
- Founders Ben Biron, Max Koeppel
- SectorsHealthcare
- Website vertisense.com
- Total Equity Funding$2.33M (USD)
in 6 rounds
- InvestorsTechstars
& 1 more
Funding Insights of Vertisense
Vertisense has successfully raised a total of $2.33M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.33M
- Total Rounds 6
- Investors Count 2
All 6 funding rounds of Vertisense with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2015 | Seed | – | – | ||
| Sep 2015 | $875,000 | Debt – Conventional | – | – | – |
| Mar 2015 | $1.7M | Seed | – | – | – |
| Sep 2014 | $500,000 | Seed | – | – | – |
| Jun 2013 | $130,000 | Seed | – | – | – |
| Feb 2013 | Seed | – | RevTech Labs | – |
2 investors in total: 2 institutional.
Investors in Vertisense
Vertisense has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Techstars and RevTech Labs.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Startups are accelerated globally without sector restrictions through structured programs. | 2006 | techstars.com | New York, United States | |
| revtechlabs.co |
Investor details for Vertisense
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Vertisense
2 people are tracked at Vertisense (2 in leadership).
| Name | Role | Group |
|---|---|---|
Ben Biron | ex-Co-Founder | Leadership |
Max Koeppel | ex-Co-Founder | Leadership |
Complete people profiles for Vertisense
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Vertisense
3 dated milestones of Vertisense across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Vertisense is founded.
- Funding First funding round.
- Funding Latest funding round, Seed,.
Competitors of Vertisense
Vertisense has 3 listed competitors in our database, 1 of them funded. They include Scram Systems, Transbiotec and Quantac.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| scramsystems.com | 1997 | Denver, United States | $5.47M | 260 | Transdermal alcohol monitoring is provided via continuous wearable device. | |
| transbiotec.com | 2004 | Seal Beach, United States | 15 | Non-invasive transdermal alcohol sensors for vehicle interlocks are developed. | ||
| quantac.co | 2016 | New York, United States | Alcohol consumption is tracked via wearable biosensor through skin diffusion. |
Detailed competitors of Vertisense
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Health Monitoring & Wearables
3 companies that operate in the same segment as Vertisense (Health Monitoring & Wearables) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Smart fitness equipment and streaming platforms are provided. | 2011 | New York, New York, United States | USD 995.53 M | USD 2.45 B | 2,894 | |
Wearable glucose monitoring patches are provided for real-time data tracking. | 1999 | San Diego, California, United States | USD 52.5 M | USD 4.66 B | 10,300 | |
Diabetes management is enabled via glucose meters and mobile apps. | 2010 | Palo Alto, California, United States | USD 201 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Vertisense
Vertisense was founded in 2011 and raised its 1st funding round 2 years after it was founded.
Vertisense is headquartered in New York, United States. It is registered at New York, New York, United States.
Vertisense is a funded company, having raised a total of $2.33M across 6 funding rounds to date.
Vertisense operates with a B2B model, focusing on leveraging cutting-edge technology, advancing health solutions through tech, developing wearables, and breathalyzer devices. Develops innovative connected breathalyzer technologies for health and safety applications. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
Vertisense's top competitors include Scram Systems, Transbiotec and Quantac.
Vertisense has 2 investors. Key investors include Techstars, and RevTech Labs.